Cell Culture Market Size, Share, Growth & Forecast | 2031
Cell Culture Market Size, Share, Growth & Forecast | 2031
Segments - Cell Culture Market by Applications (Tissue Engineering & Regenerative Medicine, Drug Screening & Development, Cancer Research, Stem Cell Technology, Vaccines, and Others), Products (Consumables [Media, Vessels, Reagent, and Serum] and Equipment [Incubator, Centrifuge, and Bioreactor]), End-users (Hospital, Biopharmaceuticals, Research Institutes, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
Upcoming
| Report ID :HC-4159
| 4.9 Rating
| 74 Reviews
| 185 Pages
| Format :
Report Description
The cell culture market size was valued at USD 22 billion in 2021 and is projected to reach USD 41 billion by 2030, expanding at a CAGR of around 12% during the forecast period, 2022 – 2030. The growth of the market is attributed to development of new three-dimensional cell culture methods and increased demand for these techniques in biopharmaceutical research and vaccine production.
Cell culture is the process of removing cells from plant or animal and growing them in a controlled environment. The cells can be extracted directly from the tissue and split using enzymatic or mechanical methods before being cultured, or they can be obtained from already established cell line or cell strain. In order to create a cell culture, several instruments and machines are used. These machines are known as instruments and several substances are used in the generation of cell cultures. These substances are used during manufacturing process thus, known as consumables. Cell culture requires conditions such as controlled physico-chemical environment, medium or substrate, gases, hormones, and growth factors.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing number of cancer patients and rising adoption of cell culture techniques are projected to drive the market.
- Rising awareness of the utilization of cell culture techniques in research is estimated to fuel the market.
- Growing cancer related research is one of the major factors driving the market
- Increased funding on research is expected to boost the market during the forecast period.
- Growing awareness about the advantages of cell-based vaccines is anticipated to propel the market during the projected period.
- High cost associated with cell biology research is projected to hamper the market growth.
- R&D investment and technological advancement in the field of cell culture is anticipated to create lucrative opportunities for the market players.
Scope of the Report
The report on the global cell culture market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Cell Culture Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2021 |
|
Historic Data |
2019–2020 |
|
Forecast Period |
2022 – 2030 |
|
Segmentation |
Applications (Tissue Engineering & Regenerative Medicine, Drug Screening & Development, Cancer Research, Stem Cell Technology, Vaccines, and Others), Products (Consumables [Media, Vessels, Reagent, and Serum] and Equipment [Incubator, Centrifuge, and Bioreactor]), End-users (Hospital, Biopharmaceuticals, Research Institutes, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Eppendorf; Promocell; Merck; Corning; Lonza; General Electric; Dickinson & Company; Becton; Thermo Fisher Scientific; Sartorius; Sigma-Aldrich Co.; Danaher Corporation; Agilent Technologies, Inc.; Miltenyi Biotec; Solida Biotech GmbH; Biospherix Ltd.; and SeraCare Life Sciences Inc. |
Market Segment Insights
The drug development segment is projected to grow at a rapid pace during the forecast period
Based on applications, the market is segregated into tissue engineering & regenerative medicine, drug screening & development, cancer research, stem cell technology, vaccines, and others. The drug development segment is projected to grow at a rapid pace during the forecast period. The drug research process in the biotechnology sector is at peak, due to the COVID-19 outbreak. Several organizations and research institutions are working on coronavirus medicines and vaccinations. Cell culture is a crucial component of drug development and medical research. Due to the simplicity with which cell monolayers can be stimulated to grow on flat surfaces, two-dimensional (2D) culture has been the favored method for many decades. The cell culture industry has evolved, and 3D cell culture has recently emerged in the market. Drug development is an expensive and time-consuming process that involves several stages, including clinical trials, preclinical validation, lead discovery & optimization, and target identification, all of which culminate to approval for clinical usage.
The consumables segment dominated the market in 2021
On the basis of products, the market is bifurcated into consumables and equipment. The consumables segment is further segregated into media, vessels, reagent, and serum. The equipment segment is further divided into incubator, centrifuge, bioreactor. The consumables segment dominated the market in 2021. Increased vertical integration, development of the biopharmaceutical industry due to increased demand, and desire for alternate media are driving the cell culture market. The media sub-segment holds the major market share. When compared to average market costs for reagents and sera, media segment is significantly less expensive, and hence consumes a less portion of revenue despite having a big volume. With the rising need for culturing in cytological research projects, the segment is likely to see significant growth during the forecast period.
The biopharmaceuticals segment accounted for a major market share in 2021
In terms of end-users, the market is fragmented into hospital, biopharmaceuticals, research institutes, and others. The biopharmaceuticals segment accounted for a major market share in 2021. Growth of the segment is attributed to growing demand for non-conventional pharmaceuticals generated as a result of bio-production of proteomically and genetically modified drugs. Advancements in technology to culture and develop tissue from cells for use in grafting, as well as approaches for individualized genomic and proteomic surgical therapies are also estimated to fuel the market.
North America dominated the global market in 2021
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2021 owing to presence of key market players and rising demand for customized medicine. Furthermore, the US government is cooperative of medical research, because healthcare is one of the country's top responsibilities.
Segments
The global cell culture market has been segmented on the basis of
Applications
- Tissue Engineering & Regenerative Medicine
- Drug Screening & Development
- Cancer Research
- Stem Cell Technology
- Vaccines
- Others
Products
- Consumables
- Media
- Vessels
- Reagent
- Serum
- Equipment
- Incubator
- Centrifuge
- Bioreactor
End-users
- Hospital
- Biopharmaceuticals
- Research Institutes
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Eppendorf
- Promocell
- Merck
- Corning
- Lonza
- General Electric
- Dickinson & Company
- Becton
- Thermo Fisher Scientific
- Sartorius
- Sigma-Aldrich Co.
- Danaher Corporation
- Agilent Technologies, Inc.
- Miltenyi Biotec
- Solida Biotech GmbH
- Biospherix Ltd.
- SeraCare Life Sciences Inc.
Competitive Landscape
Key players competing in the cell culture market include Eppendorf; Promocell; Merck; Corning; Lonza; General Electric; Dickinson & Company; Becton; Thermo Fisher Scientific; Sartorius; Sigma-Aldrich Co.; Danaher Corporation; Agilent Technologies, Inc.; Miltenyi Biotec; Solida Biotech GmbH; Biospherix Ltd.; and SeraCare Life Sciences Inc. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,
- In January 2021, Captivate Bio introduced its cell culture toolkit to assist in the fight against COVID-19 and other emerging illnesses
- In March 2021, the Gibco Human Plasma-like Medium (HPLM) from Thermo Fisher Scientific is the first cell culture media that mimics the metabolic activity of human plasma.
Frequently Asked Questions
The consumables segment held major market share in 2021.
The cell culture market is projected to expand at a CAGR of around 12% during the forecast period, 2022 – 2030.
The cell culture market size is projected to reach USD 41 billion by 2030.
North America dominated the global cell culture market in 2021.
Some of the key players in the cell culture market include Agilent Technologies, Inc.; Miltenyi Biotec; Solida Biotech GmbH; Biospherix Ltd.; and SeraCare Life Sciences Inc.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Cell Culture Market Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cell Culture Market Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cell Culture Market Market - Supply Chain
4.5. Global Cell Culture Market Market Forecast
4.5.1. Cell Culture Market Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cell Culture Market Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cell Culture Market Market Absolute $ Opportunity
5. Global Cell Culture Market Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Cell Culture Market Market Size and Volume Forecast by Applications
5.3.1. Tissue Engineering & Regenerative Medicine
5.3.2. Drug Screening & Development
5.3.3. Cancer Research
5.3.4. Stem Cell Technology
5.3.5. Vaccines
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Cell Culture Market Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Cell Culture Market Market Size and Volume Forecast by End Users
6.3.1. Hospital
6.3.2. Biopharmaceuticals
6.3.3. Research Institutes
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Cell Culture Market Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Cell Culture Market Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Cell Culture Market Demand Share Forecast, 2019-2026
8. North America Cell Culture Market Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Cell Culture Market Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Cell Culture Market Market Size and Volume Forecast by Applications
8.4.1. Tissue Engineering & Regenerative Medicine
8.4.2. Drug Screening & Development
8.4.3. Cancer Research
8.4.4. Stem Cell Technology
8.4.5. Vaccines
8.4.6. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Cell Culture Market Market Size and Volume Forecast by End Users
8.7.1. Hospital
8.7.2. Biopharmaceuticals
8.7.3. Research Institutes
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Cell Culture Market Demand Share Forecast, 2019-2026
9. Latin America Cell Culture Market Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Cell Culture Market Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Cell Culture Market Market Size and Volume Forecast by Applications
9.4.1. Tissue Engineering & Regenerative Medicine
9.4.2. Drug Screening & Development
9.4.3. Cancer Research
9.4.4. Stem Cell Technology
9.4.5. Vaccines
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Cell Culture Market Market Size and Volume Forecast by End Users
9.7.1. Hospital
9.7.2. Biopharmaceuticals
9.7.3. Research Institutes
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Cell Culture Market Demand Share Forecast, 2019-2026
10. Europe Cell Culture Market Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Cell Culture Market Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Cell Culture Market Market Size and Volume Forecast by Applications
10.4.1. Tissue Engineering & Regenerative Medicine
10.4.2. Drug Screening & Development
10.4.3. Cancer Research
10.4.4. Stem Cell Technology
10.4.5. Vaccines
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Cell Culture Market Market Size and Volume Forecast by End Users
10.7.1. Hospital
10.7.2. Biopharmaceuticals
10.7.3. Research Institutes
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Cell Culture Market Demand Share Forecast, 2019-2026
11. Asia Pacific Cell Culture Market Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Cell Culture Market Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Cell Culture Market Market Size and Volume Forecast by Applications
11.4.1. Tissue Engineering & Regenerative Medicine
11.4.2. Drug Screening & Development
11.4.3. Cancer Research
11.4.4. Stem Cell Technology
11.4.5. Vaccines
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Cell Culture Market Market Size and Volume Forecast by End Users
11.7.1. Hospital
11.7.2. Biopharmaceuticals
11.7.3. Research Institutes
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Cell Culture Market Demand Share Forecast, 2019-2026
12. Middle East & Africa Cell Culture Market Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Cell Culture Market Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Cell Culture Market Market Size and Volume Forecast by Applications
12.4.1. Tissue Engineering & Regenerative Medicine
12.4.2. Drug Screening & Development
12.4.3. Cancer Research
12.4.4. Stem Cell Technology
12.4.5. Vaccines
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Cell Culture Market Market Size and Volume Forecast by End Users
12.7.1. Hospital
12.7.2. Biopharmaceuticals
12.7.3. Research Institutes
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Cell Culture Market Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Cell Culture Market Market: Market Share Analysis
13.2. Cell Culture Market Distributors and Customers
13.3. Cell Culture Market Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Eppendorf
13.4.2. Promocell
13.4.3. Merck
13.4.4. Corning
13.4.5. Lonza
13.4.6. General Electric
13.4.7. Dickinson & Company
13.4.8. Becton
Methodology
Related Reports
Some other reports from this category!
Our Clients
